Benitec Biopharma Limited Total non-current liabilities

Total non-current liabilities of BNTC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total non-current liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total non-current liabilities for the quarter ending June 30, 2022 was $559 Thousand (a -11.97% decrease compared to previous quarter)
  • Year-over-year quarterly Total non-current liabilities decreased by -26.45%
  • Annual Total non-current liabilities for 2022 was $559 Thousand (a 162.44% increase from previous year)
  • Annual Total non-current liabilities for 2020 was $213 Thousand (a 472.58% increase from previous year)
  • Annual Total non-current liabilities for 2018 was $37.2 Thousand (a 40.91% increase from previous year)
Visit stockrow.com/BNTC for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total non-current liabilities of Benitec Biopharma Limited

Most recent Total non-current liabilitiesof BNTC including historical data for past 10 years.

Interactive Chart of Total non-current liabilities of Benitec Biopharma Limited

Benitec Biopharma Limited Total non-current liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.56 $0.64 $0.56
2021 $0.7 $0.76 $0.05
2020 $0.11 $0.16 $0.21 $0.21
2019 $0.32
2018 $0.04
2017 $0.03 $0.03
2016 $0.02 $0.01 $0.01 $0.01

Business Profile of Benitec Biopharma Limited

Sector: Healthcare
Industry: Biotechnology